Cite

Surgical integration in the overall ovarian cancer protocol is conditioned by the performance it has allowed in cytoreduction, the benefits obtained in the interest of the patients in terms of risk (postoperative mortality, severe sequelae, oncology survival criterion at 5 years).

Surgical treatment remains the fundamental technical means in the treatment of ovarian cancer. It is performed either in the “first intention” (the strand: High-Probability Clinical Diagnosis, Extemporaneous Histopathological Examination Surgery, Continued Intervention, Postoperative Adjuvant Treatments: Chemotherapy, Radiotherapy, Immunotherapy, Hormone Therapy, Second-look 6 Months), or in “second intent” (precise histopathological / pelviscopic or classic diagnosis, followed by chemotherapy, radiotherapy, immunotherapy and radical surgery).

eISSN:
1841-4036
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, other